Prognostic Implications of Sarcoidosis Granulomas　― Insights From the Multicenter Registry, the Japanese Cardiac Sarcoidosis Prognostic Study ―-Reference-Cited by-同舟云学术

Prognostic Implications of Sarcoidosis Granulomas　― Insights From the Multicenter Registry, the Japanese Cardiac Sarcoidosis Prognostic Study ―

Published:2023-06-09 Issue:6 Volume:5 Page:252-259
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Yoshida Shohei¹,Nakata Tomoaki²,Naya Masanao³,Momose Mitsuru⁴,Taniguchi Yasuyo⁵,Fukushima Yoshimitsu⁶,Moroi Masao⁷,Okizaki Atsutaka⁸,Hashimoto Akiyoshi⁹,Kiko Takatoyo¹⁰,Hida Satoshi¹¹,Takehana Kazuya¹²,Nakajima Kenichi¹³

Affiliation:

1. Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science

2. Cardiology, Hakodate Goryoukaku Hospital

3. Department of Cardiology, Hokkaido University Hospital

4. Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Woman’s Medical University

5. Department of General Medicine, Hyogo Harima-Himeji General Hospital

6. Department of Radiology, Nihon Medical School

7. Department of Cardiovascular Medicine, Toho University Ohashi Medical Center

8. Department of Radiology, Asahikawa Medical University

9. Department of Cardiology, Sapporo Medical University

10. Department of Cardiology, Fukushima Medical University

11. Department of Cardiology, Tokyo Medical University

12. Division of Cardiology, Department of Medicine II, Kansai Medical University

13. Department of Functional Imaging and Artificial Intelligence, Kanazawa University

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/5/6/5_CR-23-0031/_pdf

Reference25 articles.

1. 1. Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, et al. The use of ¹⁸F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012; 53: 241–248, doi:10.2967/jnumed.111.090662.

2. 2. Aggarwal NR, Snipelisky D, Young PM, Gersh BJ, Cooper LT, Chareonthaitawee P. Advances in imaging for diagnosis and management of cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 2015; 16: 949–958, doi:10.1093/ehjci/jev142.

3. 3. Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, et al. Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. JACC Cardiovasc Imaging 2017; 10: 1437–1447, doi:10.1016/j.jcmg.2016.11.019.

4. 4. Patel AR, Kramer CM. Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy. JACC Cardiovasc Imaging 2017; 10: 1180–1193, doi:10.1016/j.jcmg.2017.08.005.

5. 5. Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis: Digest version. Circ J 2019; 83: 2329–2388, doi:10.1253/circj.CJ-19-0508.